Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released Feb 15, 2024, before the open
10-K filed Feb 16, 2024, 47 days after period end · 0001558370-24-001275
| Metric | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $117.55M | $107.20M | $97.53M | $88.85M |
| Net Income | -$1.09M | $48.87M | $38.80M | $39.93M |
| EPS Diluted |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| -$0.01 |
| $0.27 |
| $0.21 |
| $0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.